Home
ALLO
ALLO News

Latest Allogene Therapeutics Inc. (ALLO) News on July 27, 2024

Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)

GlobeNewswire

a month ago

Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)

With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst the big guns

Simply Wall St.

a month ago

With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst the big guns

Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock?

Insider Monkey

a month ago

Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock?

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

GlobeNewswire

a month ago

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?

MT Newswires

2 months ago

Piper Sandler Starts Allogene Therapeutics With Overweight Rating, $11 Price Target

Insiders Pour Millions Into These 2 ‘Strong Buy’ Stocks

TipRanks

2 months ago

Insiders Pour Millions Into These 2 ‘Strong Buy’ Stocks

Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

GlobeNewswire

2 months ago

Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

MT Newswires

2 months ago

Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating

MT Newswires

2 months ago

HC Wainwright Adjusts Price Target on Allogene Therapeutics to $9 From $10, Keeps Buy Rating

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Zacks

2 months ago

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

MT Newswires

2 months ago

Stifel Adjusts Price Target on Allogene Therapeutics to $4.60 From $4.40, Keeps Hold Rating

MT Newswires

2 months ago

B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating

GuruFocus.com

2 months ago

Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...

MT Newswires

2 months ago

Allogene Therapeutics Prices $110 Million Offering

Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

Zacks

2 months ago

Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

GlobeNewswire

2 months ago

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

Associated Press Finance

2 months ago

Allogene Therapeutics: Q1 Earnings Snapshot

MT Newswires

2 months ago

Allogene Therapeutics Q1 Loss Narrows, Revenue Declines

Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

GlobeNewswire

2 months ago

Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?

Zacks

3 months ago

CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

GlobeNewswire

3 months ago

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

MT Newswires

3 months ago

Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

GlobeNewswire

3 months ago

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

3 months ago

Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?

Allogene Therapeutics Announces Q2 Investor Conference Participation

GlobeNewswire

4 months ago

Allogene Therapeutics Announces Q2 Investor Conference Participation

How Allogene (ALLO) Stock Stands Out in a Strong Industry

Zacks

4 months ago

How Allogene (ALLO) Stock Stands Out in a Strong Industry

We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully

Simply Wall St.

4 months ago

We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript

Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss

Zacks

4 months ago

Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Allogene Therapeutics Inc Earnings Call

GuruFocus.com

4 months ago

Allogene Therapeutics Inc (ALLO) Reports Q4 and Full Year 2023 Financials, Forecasts Cash ...

Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates

Zacks

4 months ago

Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates

Associated Press Finance

4 months ago

Allogene Therapeutics: Q4 Earnings Snapshot

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

GlobeNewswire

4 months ago

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology

Zacks

4 months ago

Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology

Allogene taps Arbor in pursuit of ‘off-the-shelf’ CAR-T therapies for autoimmune disease

BioPharma Dive

5 months ago

Allogene taps Arbor in pursuit of ‘off-the-shelf’ CAR-T therapies for autoimmune disease

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease

GlobeNewswire

5 months ago

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease

Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross

Zacks

5 months ago

Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

GlobeNewswire

5 months ago

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference

GlobeNewswire

5 months ago

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia

GlobeNewswire

5 months ago

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia

4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

Motley Fool

6 months ago

4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

LendingClub (LC) Q4 Earnings and Revenues Beat Estimates

Zacks

6 months ago

LendingClub (LC) Q4 Earnings and Revenues Beat Estimates

Calculating The Intrinsic Value Of MeridianLink, Inc. (NYSE:MLNK)

Simply Wall St.

6 months ago

Calculating The Intrinsic Value Of MeridianLink, Inc. (NYSE:MLNK)

Peapack-Gladstone (PGC) Misses Q4 Earnings and Revenue Estimates

Zacks

6 months ago

Peapack-Gladstone (PGC) Misses Q4 Earnings and Revenue Estimates

Business First Bancshares, Inc. (NASDAQ:BFST) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Business First Bancshares, Inc. (NASDAQ:BFST) Q4 2023 Earnings Call Transcript

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Stock Sinks As Market Gains: What You Should Know

Zacks

6 months ago

Loma Negra Compania Industrial Argentina S.A. Sponsored ADR (LOMA) Stock Sinks As Market Gains: What You Should Know

Bitfarms Purchases Land in Yguazu, Paraguay in Support of Transformative Fleet Upgrade & 2024 Target of 21 EH/s

GlobeNewswire

6 months ago

Bitfarms Purchases Land in Yguazu, Paraguay in Support of Transformative Fleet Upgrade & 2024 Target of 21 EH/s

Solar Stocks Have Sunk. Why an Analyst Says to Buy Sunnova and Enphase.

Barrons.com

6 months ago

Solar Stocks Have Sunk. Why an Analyst Says to Buy Sunnova and Enphase.

Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call

Business Wire

6 months ago

Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call

First Watch Announces Acquisition of Tulsa-Area Franchise Location

GlobeNewswire

6 months ago

First Watch Announces Acquisition of Tulsa-Area Franchise Location

Dynex Capital, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Business Wire

6 months ago

Dynex Capital, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

GuruFocus.com

6 months ago

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

KKR Real Estate Finance Trust Inc. to Announce Fourth Quarter 2023 Results

Business Wire

6 months ago

KKR Real Estate Finance Trust Inc. to Announce Fourth Quarter 2023 Results

Huntsman Updates Fourth Quarter 2023 Outlook; To Discuss Fourth Quarter 2023 Results on February 22, 2024; Results to be Released After Market Close on February 21, 2024

PR Newswire

6 months ago

Huntsman Updates Fourth Quarter 2023 Outlook; To Discuss Fourth Quarter 2023 Results on February 22, 2024; Results to be Released After Market Close on February 21, 2024

FirstEnergy Ohio Utilities’ Competitive Bidding Process Auction: Applications From Prospective Bidders Due No Later Than Thursday, January 25, 2024

Business Wire

6 months ago

FirstEnergy Ohio Utilities’ Competitive Bidding Process Auction: Applications From Prospective Bidders Due No Later Than Thursday, January 25, 2024

Insteel Industries Reports First Quarter 2024 Results

Business Wire

6 months ago

Insteel Industries Reports First Quarter 2024 Results

Analyst Approved: 3 Stocks Wall Street Insiders Are Whispering About

InvestorPlace

6 months ago

Analyst Approved: 3 Stocks Wall Street Insiders Are Whispering About

Fidelity National (FIS) Up 14% in 3 Months: More Room to Run?

Zacks

6 months ago

Fidelity National (FIS) Up 14% in 3 Months: More Room to Run?

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Molina Healthcare (MOH) Up 26.9% in 6 Months: What Lies Ahead?

Zacks

6 months ago

Molina Healthcare (MOH) Up 26.9% in 6 Months: What Lies Ahead?

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

6 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Gladstone Land Announces Gain on Sale of Florida Farm

ACCESSWIRE

6 months ago

Gladstone Land Announces Gain on Sale of Florida Farm

Surging Earnings Estimates Signal Upside for SMART Global Holdings, Inc. (SGH) Stock

Zacks

6 months ago

Surging Earnings Estimates Signal Upside for SMART Global Holdings, Inc. (SGH) Stock

Does the Market Have Doubts About Gray Television’s (GTN) Future?

Insider Monkey

6 months ago

Does the Market Have Doubts About Gray Television’s (GTN) Future?

Are Alarm.com Holdings, Inc. (NASDAQ:ALRM) Investors Paying Above The Intrinsic Value?

Simply Wall St.

6 months ago

Are Alarm.com Holdings, Inc. (NASDAQ:ALRM) Investors Paying Above The Intrinsic Value?

How Allogene (ALLO) Stock Stands Out in a Strong Industry

Zacks

6 months ago

How Allogene (ALLO) Stock Stands Out in a Strong Industry

New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023

Business Wire

7 months ago

New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023

Great week for Luminar Technologies, Inc. (NASDAQ:LAZR) institutional investors after losing 39% over the previous year

Simply Wall St.

7 months ago

Great week for Luminar Technologies, Inc. (NASDAQ:LAZR) institutional investors after losing 39% over the previous year

Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner

PR Newswire

7 months ago

Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner

Ameresco Receives Silver Award in 2024 Globee Awards For American Business

Business Wire

7 months ago

Ameresco Receives Silver Award in 2024 Globee Awards For American Business

Calliditas to present at JP Morgan Healthcare Conference

PR Newswire

7 months ago

Calliditas to present at JP Morgan Healthcare Conference

Koppers Holdings' (NYSE:KOP) five-year total shareholder returns outpace the underlying earnings growth

Simply Wall St.

7 months ago

Koppers Holdings' (NYSE:KOP) five-year total shareholder returns outpace the underlying earnings growth

Investors in Universal Logistics Holdings (NASDAQ:ULH) have seen respectable returns of 50% over the past five years

Simply Wall St.

7 months ago

Investors in Universal Logistics Holdings (NASDAQ:ULH) have seen respectable returns of 50% over the past five years

Allogene (ALLO) Down 20% on Strategic Changes in Pipeline

Zacks

7 months ago

Allogene (ALLO) Down 20% on Strategic Changes in Pipeline

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Zacks

7 months ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Reuters

7 months ago

UPDATE 2-Allogene to cut 22% of its workforce

Reuters

7 months ago

Allogene to cut 22% of its workforce

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

GlobeNewswire

7 months ago

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

GlobeNewswire

7 months ago

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Capital Product Partners L.P. Announces the Successful Delivery of the LNG Carrier ‘Axios II’

GlobeNewswire

7 months ago

Capital Product Partners L.P. Announces the Successful Delivery of the LNG Carrier ‘Axios II’

Universal Logistics announces $50M truck division expansion in Virginia

FreightWaves

7 months ago

Universal Logistics announces $50M truck division expansion in Virginia

Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy

Business Wire

7 months ago

Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy

Insider Sell: Xencor Inc President & CEO Bassil Dahiyat Sells 45,000 Shares

GuruFocus.com

7 months ago

Insider Sell: Xencor Inc President & CEO Bassil Dahiyat Sells 45,000 Shares

Himax to Feature Exclusive Next Gen Color Sequential Front-Lit LCoS and 3D Sensing Technologies at CES 2024

GlobeNewswire

7 months ago

Himax to Feature Exclusive Next Gen Color Sequential Front-Lit LCoS and 3D Sensing Technologies at CES 2024

CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE

ACCESSWIRE

7 months ago

CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE

Ellington Financial Completes Merger With Arlington Asset Investment Corp.

Business Wire

7 months ago

Ellington Financial Completes Merger With Arlington Asset Investment Corp.

Do Options Traders Know Something About Canada Goose (GOOS) Stock We Don't?

Zacks

7 months ago

Do Options Traders Know Something About Canada Goose (GOOS) Stock We Don't?

Privia Health to Participate in the J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Privia Health to Participate in the J.P. Morgan Healthcare Conference

Does Canada Goose Holdings Inc. (TSE:GOOS) Create Value For Shareholders?

Simply Wall St.

8 months ago

Does Canada Goose Holdings Inc. (TSE:GOOS) Create Value For Shareholders?

Volaris Reports November 2023 Traffic Results: 90% Load Factor

GlobeNewswire

8 months ago

Volaris Reports November 2023 Traffic Results: 90% Load Factor

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Criteo (NASDAQ:CRTO) shareholders have earned a 9.1% CAGR over the last three years

Simply Wall St.

8 months ago

Criteo (NASDAQ:CRTO) shareholders have earned a 9.1% CAGR over the last three years

Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?

Zacks

8 months ago

Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?

UP Fintech Holding Limited (NASDAQ:TIGR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

UP Fintech Holding Limited (NASDAQ:TIGR) Q3 2023 Earnings Call Transcript

Two Harbors Investment Corp. Announces Conversations Video Series

Business Wire

8 months ago

Two Harbors Investment Corp. Announces Conversations Video Series

Cool Company Ltd.: 2023 AGM Results Notification

Business Wire

8 months ago

Cool Company Ltd.: 2023 AGM Results Notification

Share on Social Networks: